Atomic List Manager Serial

AtomicListManagerSerialThyroid Cancer Thyroid Disease Manager. Thyroid Disease Manager. The annual incidence of thyroid cancer varies considerably in different registries, ranging from 1. Atomic List Manager Serial' title='Atomic List Manager Serial' />It is particularly elevated in Iceland and Hawaii, being nearly two times higher than in North European countries, Canada and the USA. In Hawaii, the incidence rate of thyroid cancer in each ethnic group is higher than that registered in their country of origin 1. Chinese males and Filipino females. Most of the differences are probably due to ethnic or environmental factors such as spontaneous background radiation or dietary habits 1. The American Cancer Society indicated incidence in the USA of nearly 1. The reported incidence has been increasing at more than 5yr for a decade. In sharp contrast with these data concerning the incidence of clinical thyroid cancer, is the prevalence found in autopsy series or screening programs. Libraries for Arduino. This page includes a list of community contributed libraries for Arduino. Check out the Official Arduino Libraries or Interfacing With Hardware. Autopsy studies indicate a surprising frequency ranging from 0. A survey of consecutive autopsies at Grace New Haven Hospital found 2. Another 2. 7 had discrete benign adenomas, and nearly half showed nodularity. The high prevalence may be attributed to careful examination of the gland, but probably also reects a highly selected group of older patients dying in a hospital. Up to 6 of thyroid glands in autopsied adults in the United States, and over 2. Japan, also harbour microscopically detectable foci of thyroid carcinoma, which are believed to be of no biologic signicance. I work in the businessfinance office for a large health care system that has hospitals in 5 different states. It is driving me insane that my regional director of. Altogether autopsy studies suggest that thyroid cancer is in many instances not diagnosed during life or is not the immediate cause of death. Both suggestions are in agreement with the rather leisurely growth of the majority of thyroid tumors, especially the frequent small papillary types. The annual mortality from thyroid cancer in 2. The discrepancy between incidence and mortality reects the good prognosis for most thyroid cancers. Recent statistics suggest about 6 deaths million in the USA. A classication of thyroid tumors is given in Table 1. Table 1. 8 1. Neoplasms of the ThyroidAdapted, and Revised, from WHO Classification 1. I.               I. Adenomas fig. 1. A. Follicular. Colloid variant. Embryonal. Fetal. Hurthle cell variant. B. Papillary probably malignantC. Teratoma. II. Malignant Tumors. A. Differentiated. Papillary adenocarcinoma. Pure papillary adenocarcinoma. Follicular variant of papillary thyroid carcinoma. Other variants tall cell, columnar cell, oxyphyl, solid sclerosing. Follicular adenocarcinomas variants Hurthle cell carcinoma or oxyphyl carcinoma, clear cell carcinoma, insular carcinoma. Minimally invasive. Extensively invasive. B. Medullary carcinoma. C. Undifferentiated. Giant cell. Carcinosarcoma. D. Miscellaneous. Lymphoma, sarcoma. Squamous cell epidermoid carcinoma. Fibrosarcoma. Mucoepithelial carcinoma. Metastatic tumor Thyroid tumors are rare in children and increase in frequency in each decade. Carcinomas are two three times as frequent in women as in men. In the past, it was generally believed that thyroid tumors were more frequent in areas of endemic goiter, and reports from Colombia and Austria support this association 1. Chapter 1. 1. More recent studies suggest that in iodine decient countries the number of nodules is increased and, as a consequence, also the number of thyroid cancers is increased 1. Surveys conducted in the United States found no relation between usual geographic residence and incidence of thyroid cancer. Frigidaire Lawn Tractor Manual there. ETIOLOGYMost, if not all, thyroid adenomas are monoclonal, as, presumably, are most carcinomas 1. Colloid nodules may be either mono or poly clonal. Thus tumors represent the persistent growth of the progeny of one cell which has somehow escaped the mechanisms which maintain normal cell division at about once each 8. The process of oncogenesis is conceived to be a series of events induced by genetic and environmental factors which alter growth control. At the phenomenologic level these factors may be considered as initiators and promoters. Initiators include such agents as chemicals and irradiation which induce tumors, and promoters are agents such as phenobarbital, which in rats augments TSH secretion and radically increases tumor development. In man x ray treatment is the sole known initiator, and other than elevated TSH, no promoters are known. Compounds such as phenobarbital, dilantin and PCBs, which are known thyroid tumor promoters in animals through liver microsomal hormone degrading enzyme induction leading to increased thyroid hormone metabolism, do not appear to have a detectable adverse effect in man in doses usually employed 1. Oncogenes Fig. 1. We now begin to understand oncogenesis in more details. More than 3. 0 oncogenes have been recognized in the human genome. The most likely genetic events in thyroid cancer are reported in Fig. These genes, normally silent, can become activated by chromosomal translocations, deletions, or mutations, and then can transform normal cells into a condition of uncontrolled growth. Most oncogenes appear to be closely related to normal growth factors, genes that control cell division, or to hormone receptors. In general, these genes, when turned on, promote cell growth and cell division and depress differentiation. Typically activation of one such gene may not be enough to produce malignancy, but if accompanied by expression of another oncogene, or if gene mutation or reduplication occurs, the cell may progress toward a malignant potential. Information on expression of oncogenes in human thyroid tissue is rapidly accumulating. Expression of c myc is stimulated in normal thyroid cells by TSH, and the proto oncogene is expressed in adenomas and carcinomas. Activating mutations of h ras at codons 1. Other studies, it should be noted, nd ras mutations uncommon 1. Figure 1. 8 1. 1. Possible role of oncogene activation, receptor or G protein mutation, or tumor repressor gene alteration in the induction of thyroid carcinoma. Santoro and co workers 1. This oncogene is found on chromosome 1. PTC 1, ret. PTC 2, and ret. PTC 3. As a mean, one of these translocation products is found in about 2. PTC, although in different series a large variation is observed 2. This rearrangement leads to constitutive expression of the oncogene. It has been shown that intra thyroidal expression of the retPTC1 oncogene can induce thyroid cancer 1. BRAF mutations, in the form of point mutations, are the most frequent alterations in papillary carcinoma, and undifferentiated cancers that have arisen from papillary tumors 1. PTCs 1. 24. Recently a mutational change has been associated with follicular cancers. In 5 of 8 follicular cancers, Kroll et al 1. DNA binding domain of PAX8 to domains A F of the peroxisome proliferator activater receptor PPAR gamma. The fusion oncogene is able to transform thyrocytes, so appears to be able to produce malignancies 1. Although initially thought to be exclusively present in follicular cancers, it is now known to be present in follicular adenomas as well 1. Mutation or deletion of the p. A proliferation of studies in this eld has provided many clues to thyroid tumorigenesis. Simian virus 4. 0 like sequences are found in many thyroid cancers, as well as other cancers, and the Tag gene sequence found is known to be oncogenic in animal models 1. Mutated and non functional thyroid hormone receptors are recognized in up to 9. Ultrasonography of the Thyroid Thyroid Disease Manager. Thyroid Disease Manager. ABSTRACTThyroid ultrasonography US is the most common and extremely useful, safe, and cost effective way to image the thyroid gland and its pathology. US has largely replaced the need for scintiscanning except to detect iodine avid thyroid metastases after thyroidectomy. This chapter reviews the literature discusses the science and method of performing US examines its clinical utility to assess thyroid goiters, nodules, cancers, post operative remnants, cervical lymph nodes, and metastases presents its practical value to enhance US guided aspiration biopsy of thyroid lesions FNA and mentions its importance in medical education. US reveals, with good sensitivity but only fair specificity, very important and diagnostically useful clues to the clinician and surgeon about the likelihood that a thyroid nodule is malignant. Color flow Doppler enhancement of the US images that delineates the vasculature is essential. Comprehensive understanding of the local anatomy, the specific disease process, technical skill and experience are essential to proper interpretation of the US images. Features that favor the presence of a malignant nodule include decreased echogenicity, microcalcifications, central hypervascularity, irregular margins, an incomplete halo, a tall rather than wide shape, documented enlargement of the solid portion of the nodule and associated lymphadenopathy. Several of these attributes enhance the diagnostic probability. A patients history, physical examination, and comorbidities refine the diagnosis. FNA and cytological examination of thyroid nodules and adenopathy in adults, children, and adolescents has become a major, specific, and highly diagnostic tool that is safe and inexpensive. In addition, the aspirate maybe analyzed by evolving molecular genetic methods. For complete coverage of this and related areas in Endcorinology, visit our FREE web text book, www. INTRODUCTIONUltrasonography US is the most common and most useful way to image the thyroid gland and its pathology, as recognized in guidelines for managing thyroid disorders published by the American thyroid Association 1 and other authoritative bodies. In addition to facilitating the diagnosis of clinically apparent nodules, the widespread use of US has resulted in uncovering a multitude of clinically imperceptible thyroid nodules, the overwhelming majority of which are benign. The high sensitivity for nodules but inadequate specificity for cancer has posed a management and economic problem. This chapter will address the method and utility of clinically effective thyroid US to assess the likelihood of cancer, to enhance fine needle aspiration biopsy and cytology FNA, to facilitate other thyroid diagnoses, and to teach thyroidology. Previously, imaging of the thyroid required scintiscanning to provide a map of those areas of the thyroid that accumulate and process radioactive iodine. The major premise of thyroid scanning was that thyroid cancers concentrate less radioactive iodine than healthy tissue and therefore provided triage in the selection for thyroid surgery. Unfortunately however, since benign nodules also concentrated radioactive iodine poorly, the selection process was too inefficient to be cost effective. Although, scintiscanning remains of primary importance in patients who are hyperthyroid or for detection of iodine avid tissue after thyroidectomy for thyroid cancer, US has largely replaced nuclear scanning for the majority of patients because of its higher resolution, superior correlation of true thyroid dimensions with the image, smaller expense, greater simplicity, and lack of need for radioisotope administration. The other imaging methods, computerized tomography CT, magnetic resonance imaging MRI, and 1. F FDG positron emission tomography PET are more costly than US, are not as efficient in detecting small lesions, and are best used selectively when US is inadequate to elucidate a clinical problem 2 3. As with any test, US should be used to refine a differential diagnosis only when it is needed to answer a specific diagnostic question that has been raised by the clinical history and physical examination 4. The image must then be integrated into patient management and correlated precisely with the other data. A technique been reported that helps the clinician to interpret thyroid scintigrams of goiters and functioning nodules by assembling scintiscans and US side by side as one composite image 2. Although sonography can supply very important and clinically useful clues about the nature of a thyroid lesion, it does not reliably differentiate benign lesions and cancer. However, it can help significantly. US can Depict accurately the anatomy of the neck in thyroid region,Help the student and clinician to learn thyroid palpation,Elucidate cryptic findings on physical examination,Assess the comparative size of nodules, lymph nodes, or goiters in patients who are under observation or therapy,Detect a non palpable thyroid lesion in a patient who was exposed to therapeutic irradiation,Give very important and clinically useful clues about the likelihood of malignancy,Identify the solid component of a complex nodule,Facilitate fine needle aspiration biopsy of a nodule,Evaluate for recurrence of a thyroid mass after surgery,Monitor thyroid cancer patients for early evidence of reappearance of malignancy in the thyroid bed or lymphadenopathy,Identify patients who have ultrasonic thyroid patterns that suggest diagnoses such as thyroiditis. Refine the management of patients on therapy such as antithyroid drugs,Facilitate delivery of medication or physical high energy therapy precisely into a lesion and spare the surrounding tissue,Monitor in utero the fetal thyroid for size, ultrasonic texture, and vascularity,Scrutinize the neonatal thyroid for size and location,Screen the thyroid during epidemiologic investigation in the field. TECHNICAL ASPECTSSonography depicts the internal structure of the thyroid gland and the regional anatomy and pathology without using ionizing radiation or iodine containing contrast medium 5 6. Rather, high frequency sound waves in the megahertz range ultrasound, are used to produce an image. The procedure is safe, does not cause damage to tissue and is less costly than any other imaging procedure. The patient remains comfortable during the test, which takes only a few minutes, does not require discontinuation of any medication, or preparation of the patient. The procedure is usually done with the patient reclining with the neck hyperextended but it can be done in the seated position. A probe that contains a piezoelectric crystal called a transducer is applied to the neck but since air does not transmit ultrasound, it must be coupled to the skin with a liquid medium or a gel. This instrument rapidly alternates as the generator of the ultrasound and the receiver of the signal that has been reflected by internal tissues. The signal is organized electronically into numerous shades of gray and is processed electronically to produce an image instantaneously real time. Although each image is a static picture, rapid sequential frames are processed electronically to depict motion. Two dimensional images have been standard and 3 dimentional images are an improvement in certain circumstances 7.